Humalog 50/50 Pen Report for Patients Like You

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Humalog 50/50 Pen Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Humalog 50/50 Pen?

Humalog® Mix 50/50™ Pen is a combination of insulin lispro (fast acting) and insulin lispro protamine (intermediate acting) used to treat Diabetes mellitus Type I and Type 2 to improve glycemic control.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Other	1	0

See 1 patient currently taking Humalog 50/50 Pen

Mouse over the table for more information

Reported Dosages

	125 daily
	1

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.